News

PPI
apitope
cequr
interrad
reneuron
sphere
simbec
verona
medaphor

Proton Partners International Annouces New Cancer Centre In North West

Liverpool, 15th March 2017: Proton Partners International has today announced plans to build a new £35 million cancer treatment centre in Liverpool.

Read more

The cancer centre will be built in the new £1 billion Paddington Village, part of Liverpool’s Knowledge Quarter (KQ).

This will be one of four centres built by Proton Partners International in the UK and will make the company the world’s largest developer of proton beam therapy centres. Proton Partners International is currently building three other UK cancer centres, in Newport, Northumberland and Reading, and is considering further sites.

The oncology centre, which will be known as The Rutherford Cancer Centre North West, will offer radiotherapy, chemotherapy and imaging from 2018, and proton beam therapy will be available in 2019.

Joe Anderson, Mayor of Liverpool, said: “We are delighted KQ Liverpool has been able to attract another prestigious development to Paddington Village.

“Momentum is really beginning to build for KQ Liverpool and we can expect more exciting announcements like Proton Partners International’s, which will further cement its reputation as a world leading hub in medical and life sciences research.”

Mike Moran, chief executive officer of Proton Partners International, said: “I am delighted to announce that our fourth UK centre is to be in my home city of Liverpool.

“Not only will we be bringing the top cancer technology to the North West, but we will be located at heart of what will be a world-class destination for science, innovation, education and technology.

This investment will not only enhance the level of cancer treatment available to patients, but will also bring skilled jobs to the area.”

It is expected The Rutherford Cancer Centres will each be able to treat up to 500 patients a year and treatment will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.

Proton Partners International is also building a genomics research centre at the Life Sciences Accelerator building in Liverpool which will be the first part of a health campus set to surround the £335m new Royal Liverpool Hospital. The genomics programme will support Proton Partners International’s broader research work with the University of Liverpool’s Physics Department.

ENDS

Notes to Editors

Contact details

Sophie Watson, Media House International, 0207 710 0020 orSophie@mediahouse.co.uk

Ramsay Smith, Media House International, 0207 710 0020 orRamsay@mediahouse.co.uk

About The Rutherford Cancer Centres

The Rutherford Cancer Centres are at the forefront of providing innovative cancer care and creating a better future for cancer patients. With its commitment to excellence, the centres will provide an all-encompassing cancer service, delivering world-class imaging, chemotherapy, radiotherapy and proton beam therapy treatment.

Services will be available to patients under medical insurance self-pay patients and patients referred by the NHS.

About Proton Partners International Ltd

Proton Partners International is a private limited company, registered in Wales. The company was formed following discussions between Professor Karol Sikora, former head of the World Health Organisation’s cancer programme, Professor Sir Chris Evans, the leading life sciences entrepreneur, and Neil Woodford, founding partner of Woodford Investment Management. Institutional and private investors committed to almost £100m equity finance in the company.

Professor Gordon McVie, Clinical Research Adviser to the FIRC Institute of Molecular Oncology (IFOM), is non-executive chairman and Professor Karol Sikora is chief medical adviser to the company.

The Welsh Government’s Life Sciences Investment Fund is a key investor in Proton Partners International.

For more information on Proton Partners, please visit: http://proton-int.com/

Follow us on twitter @ProtonPartners

About KQ Liverpool

KQ Liverpool is a 450-acre urban innovation district and is home to some of the world’s most influential players in science, health, technology, education, music and the creative and performing arts. With over £1bn of new developments currently underway – and a further £1bn in the pipeline – the plan is to increase the city’s employment figures, improve graduate retention and attraction rates and establish Liverpool at the forefront of the Northern Powerhouse. The unique mix of science, medicine and culture, combined with KQ Liverpool’s stunning architecture and its position at the heart of the city, has already attracted the Royal College of Physicians who have chosen KQ Liverpool as the home for their new Northern Centre of Excellence. The KQ Liverpool team is tasked with defining, creating and promoting the place and occupies the dynamic space between ambition and delivery. We believe that the whole is greater than the sum of its parts, which is why we bring together the city’s key partners to collaborate in a creative environment, allowing us to not only discover and present opportunities but to respond to them quickly. We provide consistent messaging, a single point of contact for investors and businesses and through the ‘power of place’ foster clustering, networking and knowledge transfer. www.KQLiverpool.co.uk

For more information about KQ Liverpool, please contact Michael Doran at Liverpool City Council Newscentre on 0151 233 0074 or 0780 1453918.